Matches in Wikidata for { <http://www.wikidata.org/entity/Q58671083> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q58671083 description "article scientifique publié en 2006" @default.
- Q58671083 description "article" @default.
- Q58671083 description "im Dezember 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58671083 description "wetenschappelijk artikel" @default.
- Q58671083 description "наукова стаття, опублікована у квітні 2007" @default.
- Q58671083 description "հոդված" @default.
- Q58671083 name "Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies" @default.
- Q58671083 name "Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies" @default.
- Q58671083 type Item @default.
- Q58671083 label "Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies" @default.
- Q58671083 label "Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies" @default.
- Q58671083 prefLabel "Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies" @default.
- Q58671083 prefLabel "Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies" @default.
- Q58671083 P1433 Q58671083-57A35F2B-AE9C-41EF-8C33-BA27E7169FCD @default.
- Q58671083 P1476 Q58671083-6545911B-04D0-47F2-843B-578E5E1C47F9 @default.
- Q58671083 P2093 Q58671083-1314CE91-E8B8-4379-BBBF-0F055DDBB1D4 @default.
- Q58671083 P2093 Q58671083-1F572A46-411D-46CD-97BF-F0DBD12435FF @default.
- Q58671083 P2093 Q58671083-261FAFE8-203E-45B6-8D64-56EB131A801A @default.
- Q58671083 P2093 Q58671083-F528183B-3D75-4607-88BB-8B206F3AA189 @default.
- Q58671083 P304 Q58671083-38B580B8-A18F-4552-8FBD-2E44CBBEF866 @default.
- Q58671083 P31 Q58671083-5FC168EB-12CE-4470-8B5C-A5FCB3A8CAFE @default.
- Q58671083 P356 Q58671083-B89FD6A3-E340-40F7-8120-8761309C80E6 @default.
- Q58671083 P433 Q58671083-AB54FB59-373B-4567-9333-7366AE8B9C82 @default.
- Q58671083 P478 Q58671083-8D1CAFB9-7A58-4A29-8C97-7BB26807550B @default.
- Q58671083 P50 Q58671083-B292D78F-59D4-4786-BB40-1D49B17DC434 @default.
- Q58671083 P577 Q58671083-74E047AE-5823-444F-A05F-335617FF75CB @default.
- Q58671083 P698 Q58671083-3EAA6CA9-B23A-4838-9A68-36B274161271 @default.
- Q58671083 P921 Q58671083-D5758304-8EDB-43E7-B997-271FB1FD1A8F @default.
- Q58671083 P356 J.JPBA.2006.12.010 @default.
- Q58671083 P698 17240100 @default.
- Q58671083 P1433 Q15752537 @default.
- Q58671083 P1476 "Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies" @default.
- Q58671083 P2093 "Abu Bakar Ruzilawati" @default.
- Q58671083 P2093 "Ahmad Imran" @default.
- Q58671083 P2093 "Mohd Suhaimi Abd Wahab" @default.
- Q58671083 P2093 "Zabidah Ismail" @default.
- Q58671083 P304 "1831-1835" @default.
- Q58671083 P31 Q13442814 @default.
- Q58671083 P356 "10.1016/J.JPBA.2006.12.010" @default.
- Q58671083 P433 "5" @default.
- Q58671083 P478 "43" @default.
- Q58671083 P50 Q42700244 @default.
- Q58671083 P577 "2006-12-16T00:00:00Z" @default.
- Q58671083 P698 "17240100" @default.
- Q58671083 P921 Q323936 @default.